Scrip
Genzyme manufacturing woes delay US Lumizyme approval
17 November 2009
Sue Sutter
Deficiencies at
Genzyme's beleaguered Allston, Massachusetts manufacturing plant must be resolved before the US
FDA will approve Lumizyme (alglucosidase alfa) for Pompe disease, the company said.
The FDA issued Genzyme its second complete response letter for Lumizyme on November 13th. The enzyme...
Please Login to read the full article.
17 November 2009
Sue Sutter
The FDA issued Genzyme its second complete response letter for Lumizyme on November 13th. The enzyme...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Amarin focused on CV disease to pump new life into company
- Xention looks to ion technology to jump start safer treatments
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
